Literature DB >> 6173844

[Thalassaemia intermedia. Clinical and laboratory study. Therapeutic suggestions (author's transl)].

P Triadou, R Girot, C Lapoumeroulie, R Pomarede, S Constant.   

Abstract

The clinical and laboratory criteria which distinguish thalassaemia intermedia (T.I.) from thalassaemia major were analyzed in a series of 30 patients with homozygous beta- thalassaemia, 8 of whom had T.I. The appearance of the first symptoms after the age of 2 years, the moderate spleen enlargement, the haemoglobin levels approaching 8 g/100 ml and the response to moderate transfusions over 1-year observation period were in favour of T.I. Since patients who had transfusions were clinically better than those who had none, it is suggested that T.I. patients should be treated with regular transfusions and iron chelating agents.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6173844

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  1 in total

1.  Alpha-globin loci in homozygous beta-thalassemia intermedia.

Authors:  P Triadou; C Lapoumeroulie; R Girot; D Labie
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.